2025-2026 Regular Session • US Congress Legislature
HB796: Second Chance for Moms Act
Legislative Summary
To amend the Federal Food, Drug, and Cosmetic Act to require a warning label advising that the effects of mifepristone can be counteracted, to amend the Public Health Service Act to establish a hotline to provide information to women seeking to counteract the effects of mifepristone, and for other purposes.
Demographic Impact
Overall analysis of equity impact
60% Bias
Medium ConfidenceView detailed demographic breakdown ↓Unlock Full Demographic Insights
Go beyond the overall score.
Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.
Enable full analysis features for your organization.
Contact Sales to Learn MoreOr email us directly at sales@legiequity.us.
Bill History
1/28/2025
Introduced in House
House of Representatives
1/28/2025
Referred to the House Committee on Energy and Commerce.
House of Representatives
Status Information
Current Status
Introduced(1/28/2025)
Chamber
House of Representatives
Committee
Energy And Commerce(House of Representatives)
Sponsors
Republican: 14
Primary Sponsor
Mary Miller
Republican